InvestorsHub Logo
Followers 30
Posts 5095
Boards Moderated 0
Alias Born 01/07/2020

Re: None

Friday, 01/22/2021 5:54:22 PM

Friday, January 22, 2021 5:54:22 PM

Post# of 428756
Can someone explain to me ?

1. Company A:

On the market for +8 years with 'groundbreaking Drug' - on the verge of Approval for Europe - China - a line of promising trials on Covid - Cancer - Nash. Company 'No Debt:

SP - as of today - $ 6,55
----------------------------

2. Company B:

No product on the market - only Phase 2 trials - for a rather seldom decease - relative extensive debt:

SP - as of today - $ 6,71
----------------------------

1: https://finance.yahoo.com/quote/AMRN/

2: https://finance.yahoo.com/quote/ifrx/
----------------------------

Again proves - AMRN is not valued fairly at all.

What the reason for that - Manipulation by BP - as many have suggested ?

Comparing the two Bio products above - you would say that Amarin should be above $20 - looking at facts' of potential and economy of the Company.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News